Applied Molecular Transport Inc.

Symbol: AMTI

NASDAQ

0.1942

USD

Market price today

  • -0.1055

    P/E Ratio

  • 0.0009

    PEG Ratio

  • 8.13M

    MRK Cap

  • 0.00%

    DIV Yield

Applied Molecular Transport Inc. (AMTI) Stock Price & Analysis

Shares Outstanding

41.85M

Gross Profit Margin

0.00%

Operating Profit Margin

0.00%

Net Profit Margin

0.00%

Return on Assets

-3.65%

Return on Equity

-2.19%

Return on Capital Employed

-4.71%

Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Mr. Shawn M. Cross
Full-time employees:13
City:South San Francisco
Address:450 East Jamie Court
IPO:2020-06-05
CIK:0001801777

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.

General Outlook

In simple terms, Applied Molecular Transport Inc. has 41.849 M shares that people are buying and selling right now.

Return on Investments

The company's asset efficiency, represented by a robust -3.655% return, is a testament to Applied Molecular Transport Inc.'s adeptness in optimizing resource deployment. Applied Molecular Transport Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -2.186%. Furthermore, the proficiency of Applied Molecular Transport Inc. in capital utilization is underscored by a remarkable -4.712% return on capital employed.

Stock Prices

Applied Molecular Transport Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.2059, while its low point bottomed out at $0.185. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Applied Molecular Transport Inc.'s stock market.
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2023?

There are stock number shares outstanding of Applied Molecular Transport Inc. (AMTI) on the NASDAQ in 2023.

What is P/E ratio of enterprise in 2023?

The current P/E ratio of enterprise is -0.106 in 2023.

What is the ticker symbol of Applied Molecular Transport Inc. stock?

The ticker symbol of Applied Molecular Transport Inc. stock is AMTI.

What is company IPO date?

IPO date of Applied Molecular Transport Inc. is 2020-06-05.

What is company current share price?

Current share price is 0.194 USD.

What is stock market cap today?

The market cap of stock today is 8127076.000.

What is PEG ratio in 2023?

The current 0.001 is 0.001 in 2023.

What is the number of employees in 2023?

In 2023 the company has 13.